Hurley Carolyn Katovich, Fernandez-Vina Marcelo, Hildebrand William H, Noreen Harriet J, Trachtenberg Elizabeth, Williams Thomas M, Baxter-Lowe Lee Ann, Begovich Ann B, Petersdorf Effie, Selvakumar Annamalai, Stastny Peter, Hegland Janet, Hartzman Robert J, Carston Michael, Gandham Sharavi, Kollman Craig, Nelson Gene, Spellman Stephen, Setterholm Michelle
Department of Oncology, Georgetown University, Washington, DC, USA.
Hum Immunol. 2007 Jan;68(1):30-40. doi: 10.1016/j.humimm.2006.09.004. Epub 2006 Oct 25.
The allelic diversity and associated human leukocyte antigen (HLA) disparity of 1775 bone marrow recipients and their unrelated donors, matched for six of six (1361/1775,77%), five of six (397/1775, 22%), or four of six (17/1775, 1%) HLA-A, -B, -DR antigens, were retrospectively evaluated. The comprehensive HLA analysis included the class I (A, B, C) and II (DRB1, DQA1, DQB1, DPA1, DPB1) loci. Most (>66%) of the predominantly Caucasian study population carried one or two of five to seven common alleles at each HLA locus. In spite of this limited diversity, 29% of the six of six antigen-matched transplants carried allele mismatches at HLA-A, -B, and/or -DRB1, and 92% carried at least one allele mismatch at one of the eight HLA loci tested. Of the 968 HLA-A,-B,-DRB1 allele-matched pairs, 89% carried mismatches at other HLA loci, predominantly at DP loci. The substantially greater than expected HLA allelic disparity between donor and recipient suggests extensive haplotypic diversity and underscores the importance of enhancing approaches to mitigate the deleterious effect of HLA mismatches.
对1775名骨髓受者及其无关供者的等位基因多样性及相关人类白细胞抗原(HLA)差异进行了回顾性评估,这些供受者在HLA - A、- B、- DR抗原的六个位点中,六个位点完全匹配(1361/1775,77%)、五个位点匹配(397/1775,22%)或四个位点匹配(17/1775,1%)。全面的HLA分析包括I类(A、B、C)和II类(DRB1、DQA1、DQB1、DPA1、DPB1)基因座。在主要为白种人的研究人群中,大多数(>66%)在每个HLA基因座携带五到七个常见等位基因中的一个或两个。尽管多样性有限,但在六个位点完全匹配的移植中,29%在HLA - A、- B和/或 - DRB1存在等位基因错配,92%在检测的八个HLA基因座中的一个至少存在一个等位基因错配。在968对HLA - A、- B、- DRB1等位基因匹配的供受者对中,89%在其他HLA基因座存在错配,主要是在DP基因座。供受者之间HLA等位基因差异显著大于预期,这表明单倍型多样性广泛,并强调了加强减轻HLA错配有害影响方法的重要性。